Garde Capital’s Biogen BIIB Stock Holding History

Garde Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,500	Closed	-$351K	–	141
2019 Q2	$351K	Hold	1,500	–	–	0.06%	107
2019 Q1	$355K	Hold	1,500	–	–	0.06%	106
2018 Q4	$451K	Sell	1,500 -49	-3%	-$15.6K	0.08%	119
2018 Q3	$498K	Hold	1,549	–	–	0.08%	115
2018 Q2	$450K	Hold	1,549	–	–	0.08%	116
2018 Q1	$424K	Sell	1,549 -5	-0.3%	-$1.55K	0.08%	117
2017 Q4	$495K	Sell	1,554 -20	-1%	-$6.42K	0.09%	106
2017 Q3	$493K	Hold	1,574	–	–	0.1%	107
2017 Q2	$427K	Buy	+1,574	New	+$416K	0.11%	78

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Garde Capital's BIIB Position: Q3 2019 in Review

Garde Capital sold out of Biogen (BIIB) in Q3 2019, closing a stake of 1,500 shares — an estimated $351K sold.

Garde Capital first reported a position in BIIB in Q2 2017 and held it in 9 quarters. The position peaked at $498K in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Garde Capital reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Garde Capital sold 1,500 Biogen shares in Q3 2019, an estimated $351K.
Garde Capital first reported a position in Biogen in Q2 2017 and held it in 9 quarters.
Garde Capital's Biogen position peaked at $498K in Q3 2018.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Garde Capital's 13F filing for Q3 2019, filed 13 Nov 2019.